Harmony Biosciences Holdings earnings were $180.9M for the trailing 12 months ending Jun 30, 2025, with 59.6% growth year over year. The latest HRMY earnings report on Jun 30, 2025 announced Q2 2025 earnings of $39.8M, down 12.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HRMY reported annual earnings of $145.5M, with 12.9% growth. The next HRMY earnings date is Oct 27, 2025.
HRMY past earnings growth
How has HRMY's earnings growth performed historically?
Harmony Biosciences Holdings Earnings Reports & History FAQ
What were Harmony Biosciences Holdings's earnings last quarter?
On HRMY's earnings call on Invalid Date, Harmony Biosciences Holdings (NASDAQ: HRMY) reported Q2 2025 earnings per share (EPS) of $0.69, up 245% year over year. Total HRMY earnings for the quarter were $39.78 million. In the same quarter last year, Harmony Biosciences Holdings's earnings per share (EPS) was $0.20.
When does Harmony Biosciences Holdings report earnings?
The next HRMY earnings date is Invalid Date. Add HRMY to your watchlist to be reminded of Harmony Biosciences Holdings's next earnings date.
Is Harmony Biosciences Holdings profitable or losing money?
As of the last Harmony Biosciences Holdings earnings report, Harmony Biosciences Holdings is currently profitable. Harmony Biosciences Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $180.90 million, a 57.32% increase year over year.
What was HRMY's earnings growth in the past year?
As of Harmony Biosciences Holdings's earnings date in Invalid Date, Harmony Biosciences Holdings's earnings has grown 59.6% year over year. This is 29.52 percentage points higher than the US Biotechnology industry earnings growth rate of 30.08%. HRMY earnings in the past year totalled $180.90 million.
What are Harmony Biosciences Holdings's earnings expectations?
The current EPS estimate for Harmony Biosciences Holdings's earnings report in Invalid Date is $0.81.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.